Comparative Safety of PD-1/PD-L1 Inhibitors for Cancer Patients: Systematic Review and Network Meta-Analysis

Background: Comprehensive evidence comparing treatment-related adverse events (trAEs) among PD-1/PD-L1 inhibitors is unavailable. Methods: A systematic review and network meta-analysis (NMA) was conducted. Randomized controlled trials in cancer patients treated with PD1/PD-L1 inhibitors or their com...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ya-fang, Xie, Wen-jie, Fan, Hai-yu, Du, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779807/
https://www.ncbi.nlm.nih.gov/pubmed/31632907
http://dx.doi.org/10.3389/fonc.2019.00972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779807/
https://www.ncbi.nlm.nih.gov/pubmed/31632907
http://dx.doi.org/10.3389/fonc.2019.00972

Ejemplares similares